● Recruiting

The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia

Condition: Relapsed/Refractory Immune Thrombocytopenia · Sponsor: Seoul National University Hospital

PhasePhase 2

Planned participants29

Who can joinAll sexes, 19 Years to no upper limit

Healthy volunteersNo

About this study

to investigate efficacy and safety evaluation of bortezomib in patients with relapsed/refractory immune thrombocytopenia

This description comes directly from the study's public registry record.

Talk to the study team

Dong-Yeop Shin, MD, PhD · 02-2072-7209 · stephano.dyshin@gmail.com

hye-young Jung · 82-2-6072-5207 · gracethanks@snu.ac.kr

Always discuss trial participation with your own doctor first.

Locations (4)

Seoul National University Bundang Hospital	Guri-si, South Korea	Recruiting
Seoul National University Hospital	Seoul, South Korea	Recruiting
SMG-SNU Boramae Medical Center	Seoul, South Korea	Recruiting
Seoul National University Hospital	Seoul, South Korea	Not Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05599880